Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST)

Mepolizumab was effective in reducing the burden of SA by significantly reducing CSEs, reducing OCS use and HCRU, and improving lung function and asthma control, which could translate to improvements in health-related quality of life in patients with SA and high OCS dependency in the countries studied. A graphical abstract is available with this article.

Authors

Institutions

Publication Details

Journal
Advances in Therapy
Published
2024-08-31
DOI
https://doi.org/10.1007/s12325-024-02967-x
Citations
17
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
5.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST)

Riyad Al‐Lehebi, María Laucho-Contreras, Saeed Noibi, Gabriela de Azevedo Abreu et al.
17 citations
Advances in Therapy
Asthma and respiratory diseases
5.55
article

Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST)

Riyad Al‐Lehebi, María Laucho-Contreras, Saeed Noibi, Gabriela de Azevedo Abreu, Alejandro Raimondi, Debora França dos Santos, Sevim Bavbek, Juliana Queiroz, Gur Levy, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, Cláudia Soares, Elizabeth A. Garcia, Patricia Fernández, Bassam Mahboub, Alejandra Galeano Mesa
article en
17 citations

Abstract

Mepolizumab was effective in reducing the burden of SA by significantly reducing CSEs, reducing OCS use and HCRU, and improving lung function and asthma control, which could translate to improvements in health-related quality of life in patients with SA and high OCS dependency in the countries studied. A graphical abstract is available with this article.

Advances in TherapyVol. 41(11)
Dubai Health Authority (AE), Alfaisal University (SA), Ankara University (TR), Universidad de Los Andes (CO), Rashid Hospital (AE), King Fahd Medical City (SA), Kuwait University (KW), University of Jeddah (SA), Agencia Nacional de Investigación y Desarrollo (CL), Fundación Neumológica Colombiana (CO), Yashoda Hospital (IN), Fundación Santa Fe de Bogotá (CO), Secretaría de Salud de Bogotá (CO), GlaxoSmithKline (Brazil) (BR)
Openalex Percentile: Top 3%
Asthma and respiratory diseases
5.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.